Although current evidence suggests a potential association between GALP and PCOS-related GDM, further clinical studies are required to elucidate its precise mechanistic role and evaluate its feasibility as either a predictive biomarker or therapeutic target. Here, GALP is linked to polycystic ovary syndrome.